These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 30744284)

  • 1. [The progress and challenge of Japanese encephalitis control and prevention in China].
    Wang HY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Feb; 53(2):133-135. PubMed ID: 30744284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
    Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of Japanese encephalitis epidemic in Wuhan, China, 2009-2010.
    Hu Q; Chen B; Zhu Z; Tian J; Zhou Y; Zhang X; Zheng X
    PLoS One; 2013; 8(1):e52687. PubMed ID: 23326348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China.
    Liu X; Yu Y; Li M; Liang G; Wang H; Jia L; Dong G
    Vaccine; 2011 Mar; 29(11):2127-30. PubMed ID: 21237278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiological characteristics and related influencing factors on Japanese encephalitis in Hainan Province].
    Pan XH; Sun LY; Wang CL; Zhu J; Fu ZW; Zeng ZC; Zeng XX; Yan XJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 May; 30(5):471-4. PubMed ID: 19799143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adults in Northwest China experienced the largest outbreak of Japanese encephalitis in history 10 years after the Japanese encephalitis vaccine was included in the national immunization program: A retrospective epidemiological study.
    Zhang X; Jin N; Tu A; Dong M; Shi T; Ren X; Liu S; Zhao X; Liu J; Wu Z; Li Y; Wu D; Wang H; Wang H; Hu Y; Zhang B; Wang W; Meng L
    J Med Virol; 2023 May; 95(5):e28782. PubMed ID: 37212323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Japanese encephalitis and Japanese encephalitis virus in mainland China.
    Zheng Y; Li M; Wang H; Liang G
    Rev Med Virol; 2012 Sep; 22(5):301-22. PubMed ID: 22407526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China.
    Yin Z; Beeler Asay GR; Zhang L; Li Y; Zuo S; Hutin YJ; Ning G; Sandhu HS; Cairns L; Luo H;
    Vaccine; 2012 Aug; 30(37):5569-77. PubMed ID: 22698453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction patterns of Japanese encephalitis incidence following vaccine introduction into long-term expanded program on immunization in Yunnan Province, China.
    Hu XT; Li QF; Ma C; Zhao ZX; He LF; Tang TT; Yu W; Owiti P
    Infect Dis Poverty; 2019 Dec; 8(1):102. PubMed ID: 31818328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Fischer M; Lindsey N; Staples JE; Hills S;
    MMWR Recomm Rep; 2010 Mar; 59(RR-1):1-27. PubMed ID: 20224546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.
    Hegde NR; Gore MM
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-18. PubMed ID: 28301270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the expanded program on immunization on the incidence of Japanese encephalitis in different regions of Mainland China: An interrupt time series analysis.
    Shi T; Meng L; Li D; Jin N; Zhao X; Zhang X; Liu Y; Zheng H; Zhao X; Li J; Shen X; Ren X
    Acta Trop; 2022 Sep; 233():106575. PubMed ID: 35768039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.
    Cao L; Fu S; Gao X; Li M; Cui S; Li X; Cao Y; Lei W; Lu Z; He Y; Wang H; Yan J; Gao GF; Liang G
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004686. PubMed ID: 27139722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Outbreak of Japanese Encephalitis in Adults in Northern China, 2013: A Population-Based Study.
    Li X; Gao X; Fu S; Wang H; Lu Z; He Y; Lei W; Liang G
    Vector Borne Zoonotic Dis; 2019 Jan; 19(1):26-34. PubMed ID: 29741995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of different vaccine strategies for the control of Japanese encephalitis in mainland China from 1961 to 2020: A quantitative analysis.
    Shi T; Meng L; Li D; Jin N; Zhao X; Zhang X; Liu Y; Zheng H; Zhao X; Li J; Shen X; Ren X
    Vaccine; 2022 Oct; 40(43):6243-6254. PubMed ID: 36137902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.
    Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A
    Vaccine; 2013 Dec; 32(1):119-23. PubMed ID: 24176496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
    Zhou B; Jia L; Xu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV-Primed Children in the Philippines.
    Capeding MR; Alberto ER; Bouckenooghe A; Laot TM; Chansinghakul D; Monfredo C; Machabert T; Feroldi E
    J Infect Dis; 2018 Jan; 217(4):567-571. PubMed ID: 29325161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological trends and characteristics of Japanese encephalitis changed based on the vaccination program between 1960 and 2013 in Guangxi Zhuang Autonomous Region, southern China.
    Yang Y; Liang N; Tan Y; Xie Z
    Int J Infect Dis; 2016 Apr; 45():135-8. PubMed ID: 26972041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.